Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06574620

Title field or adapter rule

{'original_value': 'Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:25.647606+00:00

Published At

2026-09-16T00:00:00+00:00

Record Updated At

2026-09-16

Source Retrieved At

2026-10-31T22:17:56.788771+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Ductal Adenocarcinoma", "Resectable Pancreatic Ductal Adenocarcinoma", "Borderline Resectable Pancreatic Ductal Adenocarcinoma", "Locally Advanced Pancreatic Ductal Adenocarcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-16", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06574620"

protocolSection.identificationModule.officialTitle

"Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Resectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Borderline Resectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Locally Advanced Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Borderline Resectable Cohort', 'Locally Advanced Cohort', 'Resectable Cohort'], 'description': 'Analyses of the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and other molecules in the sample.', 'name': 'Genetic testing', 'type': 'GENETIC'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Borderline Resectable Cohort', 'Locally Advanced Cohort', 'Resectable Cohort'], 'description': 'Optional collection of tumour tissue and normal tissue after the last dose of treatment.', 'name': 'Optional biopsy', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Borderline Resectable Cohort', 'Locally Advanced Cohort', 'Resectable Cohort'], 'description': 'Collection of tumour tissue and normal tissue from biopsy or standard resection surgery prior to the first dose of treatment.', 'name': 'Tissue collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.